Avicanna
Advantage
Disrupting the Cannabinoid
Industry with Science
A Leader in Biopharmaceutical Advancements with Natural Cannabinoids
Avicanna is a Canadian vertically-integrated biopharmaceutical company focused on evidence-based utility of cannabinoids.
Commercial stage with diversified and high margin income streams in Canada, USA, and Latin America
- Comprehensive commercial portfolio – consumer retail, and medical cannabis
- Multinational with international foot-print – USA, Canada, and LATAM
- Partnership with Medical Cannabis by Shopper’s Drug Mart Inc. – RHO Phyto and Pura Earth branded nation-wide in Canada
Proven scientific platform, including R&D, pre-clinical and clinical infrastructure
- Cannabinoid drug development expertise – 20+ advanced commercial products and pharmaceutical pipeline
- World-Class collaborations – with leading Canadian academic and clinical institutions
- JLABS @ Toronto, Johnson & Johnson Innovation Centre in the MaRS Discovery District, R&D headquarters
Established and Proven low-cost vertical integration
- Two (2) Colombian majority-owned subsidiaries – cultivation footprint of 480,000 sq feet with industrial extraction capacity
- Organic and sustainable cultivation – ranked highest amongst global cannabis companies in a corporate sustainability assessment – issued by S&P Global in 2020
Hemp-derived Consumer Retail Products
Medical Products
Pharmaceutical Pipeline
Active Pharmaceutical Ingredients
Genetics and Seeds
